Viewing Study NCT01964950


Ignite Creation Date: 2025-12-24 @ 4:48 PM
Ignite Modification Date: 2026-01-31 @ 9:51 AM
Study NCT ID: NCT01964950
Status: COMPLETED
Last Update Posted: 2017-04-13
First Post: 2013-10-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Sulfonylurea
Sponsor: Takeda
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Surveillance View
Keywords:

Keywords

Keyword Brief Keyword Text View
None drug therapy View